tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz
PremiumCompany AnnouncementsAlvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz
17d ago
Alvotech and Teva Settle With Regeneron on U.S. Launch Timing for Eylea Biosimilar AVT06
Premium
Company Announcements
Alvotech and Teva Settle With Regeneron on U.S. Launch Timing for Eylea Biosimilar AVT06
22d ago
Alvotech, Teva reach settlement and license agreement with Regeneron for AVT06
Premium
The Fly
Alvotech, Teva reach settlement and license agreement with Regeneron for AVT06
22d ago
Alvotech announces European Commission approval for AVT03
PremiumThe FlyAlvotech announces European Commission approval for AVT03
2M ago
Alvotech’s Gobivaz® Receives European Approval as First Simponi® Biosimilar
Premium
Company Announcements
Alvotech’s Gobivaz® Receives European Approval as First Simponi® Biosimilar
2M ago
Alvotech price target lowered to $10 from $13 at UBS
Premium
The Fly
Alvotech price target lowered to $10 from $13 at UBS
2M ago
ALVO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsALVO Upcoming Earnings Report: What to Expect?
2M ago
Alvotech’s Gobivaz Biosimilar Gains UK Approval
Premium
Company Announcements
Alvotech’s Gobivaz Biosimilar Gains UK Approval
2M ago
Alvotech price target lowered to $10 from $28 at Northland
Premium
The Fly
Alvotech price target lowered to $10 from $28 at Northland
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100